Bill Snyder

March 24, 2016

Nobel laureate Lefkowitz set for next Discovery Lecture

Robert Lefkowitz, M.D., who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on March 31.

By Bill Snyder
alarm clock
March 17, 2016

Study suggests cancer’s ‘clock’ can be rewound

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.

By Bill Snyder
March 17, 2016

Research Staff Awards honor contributions to discovery

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 12th annual Research Staff Awards luncheon at the University Club.

By Bill Snyder
March 17, 2016

Study explores gene’s role in protecting HIV patients from TB

An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.

By Bill Snyder
March 17, 2016

Cunningham Award winner

Lisa Poole, a graduate student in the lab of David Cortez, Ph.D., received the 2016 Leon W. Cunningham Award for Excellence in Biochemistry last week during the Biochemistry Department’s annual retreat at the Student Life Center.

By Bill Snyder
March 10, 2016

Pioneering diabetes researcher Park celebrates 100th birthday

Pioneering Vanderbilt diabetes researcher Charles R. “Rollo” Park, M.D., celebrated his 100th birthday on March 2 at the Heritage of Brentwood with his wife of more than 70 years, Jane Park, Ph.D., professor emerita of Molecular Physiology and Biophysics.

By Bill Snyder
March 9, 2016

Eye of a cytokine storm

A new animal model can be used to “dissect” the inflammatory response to infection.
By Bill Snyder
March 7, 2016

Vanderbilt researchers identify potential antibody treatment for H7 avian flu

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.
By Bill Snyder
March 3, 2016

Study reveals possible ‘dimmer switch’ drug for Rett syndrome

Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.
By Bill Snyder
March 3, 2016

Study seeks to ease pediatric HIV infection rates in Africa

Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce.
By Bill Snyder
March 3, 2016

VUMC’s Chekmenev elected to Russian Academy of Sciences

Vanderbilt researcher Eduard Chekmenev, Ph.D., has been elected to the Russian Academy of Sciences (RAS) for his efforts to develop imaging markers for cancer and lung disease using hyperpolarized magnetic resonance imaging (MRI).
By Bill Snyder
February 25, 2016

Grant bolsters rheumatoid arthritis research

C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.
By Bill Snyder
1 … 72 73 74 75 76 … 110